These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Course and treatment of myasthenia gravis during pregnancy]. Klehmet J; Dudenhausen J; Meisel A Nervenarzt; 2010 Aug; 81(8):956-62. PubMed ID: 20411231 [TBL] [Abstract][Full Text] [Related]
25. [Myasthenia and pregnancy]. Dusek H Cesk Gynekol; 1981 Jun; 46(5):373-4. PubMed ID: 7273189 [No Abstract] [Full Text] [Related]
26. [Myasthenia and pregnancy]. Stoĭkov S; Popov I Akush Ginekol (Sofiia); 1999; 38(4):48-51. PubMed ID: 10726355 [TBL] [Abstract][Full Text] [Related]
27. Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies. Rajakulendran S; Viegas S; Spillane J; Howard RS J Neurol; 2012 Dec; 259(12):2736-9. PubMed ID: 22955633 [No Abstract] [Full Text] [Related]
28. 3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies. Evoli A; Alboini PE; Damato V; Iorio R Neurology; 2016 Mar; 86(11):1070-1. PubMed ID: 26873957 [No Abstract] [Full Text] [Related]
29. [Myasthenia gravis: pregnancy, delivery and the fate of the newborn. (Casuistics and synopsis of existing facts) (author's transl)]. Zivný J; Dolezal A; Vacek J; Kucera E; Komanec J; Trnka V Cesk Gynekol; 1978 Jun; 43(5):382-7. PubMed ID: 566635 [No Abstract] [Full Text] [Related]
30. Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen. Stergiou C; Lazaridis K; Zouvelou V; Tzartos J; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Behin A; Sharshar T; De Baets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Gilhus NE; Casasnovas Pons C; Pitha J; Jakubíkova M; Hanisch F; Bogomolovas J; Labeit D; Labeit S; Tzartos SJ J Neuroimmunol; 2016 Mar; 292():108-15. PubMed ID: 26943968 [TBL] [Abstract][Full Text] [Related]
31. Antibodies to low density lipoprotein receptor-related protein 4 in seronegative myasthenia gravis. Richman DP Arch Neurol; 2012 Apr; 69(4):434-5. PubMed ID: 22158717 [No Abstract] [Full Text] [Related]
32. A novel MuSK cell-based myasthenia gravis diagnostic assay. Han J; Zhang J; Li M; Zhang Y; Lv J; Zhao X; Wang S; Wang L; Yang H; Han S; Fang H; Gao F J Neuroimmunol; 2019 Dec; 337():577076. PubMed ID: 31655425 [TBL] [Abstract][Full Text] [Related]
33. The role of antibodies in myasthenia gravis. De Baets M; Stassen MH J Neurol Sci; 2002 Oct; 202(1-2):5-11. PubMed ID: 12220686 [TBL] [Abstract][Full Text] [Related]
34. Frequency of seronegativity in adult-acquired generalized myasthenia gravis. Chan KH; Lachance DH; Harper CM; Lennon VA Muscle Nerve; 2007 Nov; 36(5):651-8. PubMed ID: 17654558 [TBL] [Abstract][Full Text] [Related]
39. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)]. Sanadze AG; Sidnev DV; Karganov MIu Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492 [TBL] [Abstract][Full Text] [Related]
40. Myasthenia gravis. Diagnostic methods and control measures for a chronic disease. Juhn MS Postgrad Med; 1993 Oct; 94(5):161-4, 167-71, 174. PubMed ID: 8415329 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]